Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance.
- NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_assertion description "[A total of 471 treatment-naive patients with histologically proven chronic hepatitis C virus (HCV) infection (106 with cirrhosis; 185 with HCV genotype 1 [HCV-1], 157 with HCV genotype 2 [HCV-2], 92 with HCV genotype 3 [HCV-3] and 37 with HCV genotype 4 [HCV-4]) were consecutively treated with PEG-IFN-alpha2b 1.5 microg weekly and weight-based RBV.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance.
- NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_assertion evidence source_evidence_literature NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance.
- NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_assertion SIO_000772 19578243 NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance.
- NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_assertion wasDerivedFrom befree-20150227 NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance.
- NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_assertion wasGeneratedBy ECO_0000203 NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP977930.RAgqRGjFBNvk8eeYv9go376NwQi5Maif6speqBU85W6G8130_provenance.